AAAAAA

   
Results: 1-8 |
Results: 8
Primary epithelioid sarcoma of the vulva
Authors: Kasamatsu, T Hasegawa, T Tsuda, H Okada, S Sawada, M Yamada, T Tsunematsu, R Ohmi, K Mizuguchi, K Kawana, T
Citation: T. Kasamatsu et al., Primary epithelioid sarcoma of the vulva, INT J GYN C, 11(4), 2001, pp. 316-320
Prognostic factors of stage IV epithelial ovarian cancer: A multicenter retrospective study
Authors: Akahira, JI Yoshikawa, H Shimizu, Y Tsunematsu, R Hirakawa, T Kuramoto, H Shiromizu, K Kuzuya, K Kamura, T Kikuchi, Y Kodama, S Yamamoto, K Sato, S
Citation: Ji. Akahira et al., Prognostic factors of stage IV epithelial ovarian cancer: A multicenter retrospective study, GYNECOL ONC, 81(3), 2001, pp. 398-403
A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: A Japanese Cooperative Study
Authors: Katsumata, N Tsunematsu, R Tanaka, K Terashima, Y Ogita, S Hoshiai, H Kohno, I Hirabayashi, K Yakushiji, M Noda, K Taguchi, T
Citation: N. Katsumata et al., A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: A Japanese Cooperative Study, ANN ONCOL, 11(12), 2000, pp. 1531-1536
Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication
Authors: Nakayama, K Nagahama, H Minamishima, YA Matsumoto, M Nakamichi, I Kitagawa, K Shirane, M Tsunematsu, R Tsukiyama, T Ishida, N Kitagawa, M Nakayama, K Hatakeyama, S
Citation: K. Nakayama et al., Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication, EMBO J, 19(9), 2000, pp. 2069-2081
Hypercalcemia due to parathyroid hormone-related protein produced by primary ovarian clear cell adenocarcinoma: Case report
Authors: Tsunematsu, R Saito, T Iguchi, H Fukuda, T Tsukamoto, N
Citation: R. Tsunematsu et al., Hypercalcemia due to parathyroid hormone-related protein produced by primary ovarian clear cell adenocarcinoma: Case report, GYNECOL ONC, 76(2), 2000, pp. 218-222
Quantitative reduction of type I adenylyl cyclase in human alcoholics
Authors: Sohma, H Hashimoto, E Shirasaka, T Tsunematsu, R Ozawa, H Boissl, KW Boning, J Riederer, P Saito, T
Citation: H. Sohma et al., Quantitative reduction of type I adenylyl cyclase in human alcoholics, BBA-MOL BAS, 1454(1), 1999, pp. 11-18
Phase II dose escalation: A novel approach to balancing efficacy and toxicity of anticancer agents
Authors: Fujiwara, K Kohno, I Tanaka, K Ogita, S Sasaki, Y Hirabayashi, K Yakushiji, M Tsunematsu, R Terashima, Y Taguchi, T Ohashi, Y Noda, K
Citation: K. Fujiwara et al., Phase II dose escalation: A novel approach to balancing efficacy and toxicity of anticancer agents, ANTICANC R, 19(1B), 1999, pp. 639-644
Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer
Authors: Tang, X Tanemura, K Ye, WM Ohmi, K Tsunematsu, R Yamada, T Katsumata, N Sonoda, T
Citation: X. Tang et al., Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer, JPN J CLIN, 28(11), 1998, pp. 673-678
Risultati: 1-8 |